NCT01806064 2020-10-19Randomized Phase 2 Trial of Axitinib and TRC105 Versus Axitinib Alone in Patients Renal Cell CarcinomaTracon Pharmaceuticals Inc.Phase 1/2 Terminated173 enrolled 17 charts
NCT02664961 2019-07-23Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)Tracon Pharmaceuticals Inc.Phase 2 Terminated3 enrolled 11 charts